Labocanna

Labocanna Debt Growth

The Year-over-Year Debt Growth of Labocanna (LCN.WA) as of Oct 19, 2026 is -99.47 %. In the previous year, Year-over-Year Debt Growth was 34.48 % — a change of -388.46% (lower).

Debt Growth

-99.47 %

YoY

-388.46%

Last updated:

Year-over-Year Debt Growth of Labocanna is 2022 -99.47 % . Year-over-Year Debt Growth of Labocanna was 2021 34.48 % . It decreases by -388.46% lower compared to the previous year.

The Labocanna Debt Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt Growth
Date
Debt Growth
Jan 1, 2016
194.12 PLN
Jan 1, 2017
24.00 PLN
Jan 1, 2018
-3.23 PLN
Jan 1, 2019
-3.33 PLN
Jan 1, 2020
0.00 PLN
Jan 1, 2021
34.48 PLN
Jan 1, 2022
-99.47 PLN
The Labocanna Debt Growth history
YEARDebt GrowthYoY
-99.47 %-388.46%
34.48 %—
0.00-100.00%
-3.33 %+3.33%
-3.23 %-113.44%
24.00 %-87.64%
194.12 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Labocanna Stock analysis

What does Labocanna do? Labocanna SA is a pharmaceutical company based in Koszalin, Poland, operating within the Health Care sector. The company's primary focus is on the hemp business, as indicated by its operational description. It completed its initial public offering (IPO) on July 4, 2011, marking its entry into the public market. Labocanna SA is listed under the ticker symbol LCN.WA and holds the ISIN code PLCCTLS00017. The company's headquarters are located in Koszalin, a city in the West Pomeranian Voivodeship (Woj. Zachodniopomorskie) of Poland. Its official website is https://labocanna.pl/, which serves as a primary source of information about its operations and offerings. The company operates within the pharmaceutical industry, though specific details about its products, services, or market position are not provided in the available information. Labocanna SA's activities are centered around the hemp sector, which may include the development, production, or distribution of hemp-related products, though the exact nature of these activities remains unspecified. The company's public listing and headquarters location are key identifiers for its operational and financial profile. No additional details regarding founding year, key personnel, acquisitions, or financial figures are included in the provided data. Labocanna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Labocanna stock

Year-over-Year Debt Growth of Labocanna is -99.47 % in 2022.

On Eulerpool you can find the complete historical development of Year-over-Year Debt Growth Labocanna since 2006 – with annual values, charts, and detailed analysis.

Debt growth measures the percentage change in total debt. Rising debt growth should be compared with revenue and earnings growth to assess sustainability.

To evaluate Year-over-Year Debt Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Debt Growth.

Year-over-Year Debt Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Debt Growth's Labocanna historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — Labocanna

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — Labocanna